Katharine A. Kott

573 total citations
23 papers, 321 citations indexed

About

Katharine A. Kott is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Katharine A. Kott has authored 23 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Katharine A. Kott's work include Cardiac Imaging and Diagnostics (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Katharine A. Kott is often cited by papers focused on Cardiac Imaging and Diagnostics (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Katharine A. Kott collaborates with scholars based in Australia, New Zealand and Canada. Katharine A. Kott's co-authors include Gemma A. Figtree, Stephen T. Vernon, Jean Yang, Thomas Hansen, John O’Sullivan, Stuart M. Grieve, Pauline Johnson, James D. Johnson, Yu Hsuan Carol Yang and Marta Szabat and has published in prestigious journals such as Nature Communications, The Journal of Immunology and International Journal of Molecular Sciences.

In The Last Decade

Katharine A. Kott

23 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katharine A. Kott Australia 11 120 87 78 56 37 23 321
Masahiro Fujii Japan 12 132 1.1× 50 0.6× 72 0.9× 83 1.5× 43 1.2× 52 449
Kristoffer Niss Denmark 8 93 0.8× 44 0.5× 32 0.4× 99 1.8× 63 1.7× 13 335
Chengfu Cao China 11 220 1.8× 59 0.7× 88 1.1× 38 0.7× 38 1.0× 25 415
Carin Gustavsson Sweden 10 107 0.9× 44 0.5× 39 0.5× 70 1.3× 29 0.8× 15 476
Daniëlle Hof Switzerland 10 133 1.1× 24 0.3× 77 1.0× 78 1.4× 53 1.4× 20 322
Wolfgang Derer Germany 8 114 0.9× 31 0.4× 78 1.0× 34 0.6× 16 0.4× 14 262
Arvind Sood United Kingdom 10 324 2.7× 122 1.4× 223 2.9× 48 0.9× 50 1.4× 19 581
Yudai Shimoda Japan 9 154 1.3× 67 0.8× 223 2.9× 150 2.7× 17 0.5× 14 465
Guerline Lambert United States 8 101 0.8× 30 0.3× 54 0.7× 26 0.5× 34 0.9× 12 299
Annalisa Moregola Italy 11 142 1.2× 67 0.8× 32 0.4× 183 3.3× 51 1.4× 20 410

Countries citing papers authored by Katharine A. Kott

Since Specialization
Citations

This map shows the geographic impact of Katharine A. Kott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharine A. Kott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharine A. Kott more than expected).

Fields of papers citing papers by Katharine A. Kott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharine A. Kott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharine A. Kott. The network helps show where Katharine A. Kott may publish in the future.

Co-authorship network of co-authors of Katharine A. Kott

This figure shows the co-authorship network connecting the top 25 collaborators of Katharine A. Kott. A scholar is included among the top collaborators of Katharine A. Kott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharine A. Kott. Katharine A. Kott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Besnier, Marie, Owen Tang, Katharine A. Kott, et al.. (2023). High-Throughput Measure of Mitochondrial Superoxide Levels as a Marker of Coronary Artery Disease to Accelerate Drug Translation in Patient-Derived Endothelial Cells Using Opera Phenix® Technology. International Journal of Molecular Sciences. 25(1). 22–22. 4 indexed citations
2.
Kott, Katharine A., Michael P. Gray, Peter Riis Hansen, et al.. (2023). Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease. Biomolecules. 13(8). 1187–1187. 4 indexed citations
3.
Zhu, Dantong, Stephen T. Vernon, Jing Wu, et al.. (2023). Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery Cohort. Biomolecules. 13(6). 917–917. 13 indexed citations
4.
Kott, Katharine A., Stephen T. Vernon, Thomas Hansen, et al.. (2023). Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease. Clinical & Translational Immunology. 12(11). e1462–e1462. 1 indexed citations
5.
Kozor, Rebecca, Aderonke Abiodun, Katharine A. Kott, & Charlotte Manisty. (2022). Non-invasive Imaging in Women With Heart Failure — Diagnosis and Insights Into Disease Mechanisms. Current Heart Failure Reports. 19(3). 114–125. 3 indexed citations
6.
George, Jacob, et al.. (2022). The Translation and Commercialisation of Biomarkers for Cardiovascular Disease—A Review. Frontiers in Cardiovascular Medicine. 9. 897106–897106. 2 indexed citations
7.
Kott, Katharine A., M. D. Bishop, Louise Cullen, et al.. (2022). Biomarker Development in Cardiology: Reviewing the Past to Inform the Future. Cells. 11(3). 588–588. 10 indexed citations
8.
Vernon, Stephen T., Katharine A. Kott, Thomas Hansen, et al.. (2022). Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-α-1,3 (α-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment–Elevated Myocardial Infarction. Arteriosclerosis Thrombosis and Vascular Biology. 42(3). 352–361. 28 indexed citations
9.
Vernon, Stephen T., Owen Tang, Tai-Yun Kim, et al.. (2021). Metabolic Signatures in Coronary Artery Disease: Results from the BioHEART-CT Study. Cells. 10(5). 980–980. 17 indexed citations
10.
Besnier, Marie, Christine Yu, Katharine A. Kott, et al.. (2021). Patient Endothelial Colony-Forming Cells to Model Coronary Artery Disease Susceptibility and Unravel the Role of Dysregulated Mitochondrial Redox Signalling. Antioxidants. 10(10). 1547–1547. 10 indexed citations
11.
Kim, Tai-Yun, Owen Tang, Stephen T. Vernon, et al.. (2021). A hierarchical approach to removal of unwanted variation for large-scale metabolomics data. Nature Communications. 12(1). 4992–4992. 28 indexed citations
12.
Kott, Katharine A., Marie‐Christine Morel‐Kopp, Stephen T. Vernon, et al.. (2021). Association of Global Coagulation Profiles With Cardiovascular Risk Factors and Atherosclerosis: A Sex Disaggregated Analysis From the BioHEART‐CT Study. Journal of the American Heart Association. 10(20). e020604–e020604. 8 indexed citations
13.
Vernon, Stephen T., Katharine A. Kott, Thomas Hansen, et al.. (2021). Coronary artery disease burden in women poorly explained by traditional risk factors: Sex disaggregated analyses from the BioHEART-CT study. Atherosclerosis. 333. 100–107. 5 indexed citations
14.
Vernon, Stephen T., Katharine A. Kott, Thomas Hansen, Sheryl van Nunen, & Gemma A. Figtree. (2020). 446 Association of Mammalian Oligosaccharide Galactose-α-1,3-galactose (α-Gal) With Atherosclerotic Coronary Artery Disease. Heart Lung and Circulation. 29. S237–S238. 1 indexed citations
15.
Allahwala, U., et al.. (2020). Predictors and Prognostic Implications of Well-Matured Coronary Collateral Circulation in Patients with a Chronic Total Occlusion (CTO). International Heart Journal. 61(2). 223–230. 16 indexed citations
16.
Kott, Katharine A., et al.. (2020). 738 Microvascular Dysfunction: Assessment of Risk Factors in Patients With Positive Stress Tests but No Obstructive Epicardial Coronary Artery Disease. Heart Lung and Circulation. 29. S368–S368. 1 indexed citations
17.
Kott, Katharine A., Stephen T. Vernon, Thomas Hansen, et al.. (2019). Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort study. BMJ Open. 9(9). e028649–e028649. 38 indexed citations
18.
19.
Yang, Yu Hsuan Carol, Marta Szabat, Katharine A. Kott, et al.. (2011). Paracrine signalling loops in adult human and mouse pancreatic islets: netrins modulate beta cell apoptosis signalling via dependence receptors. Diabetologia. 54(4). 828–842. 45 indexed citations
20.
Kott, Katharine A., et al.. (2008). CD45 Regulates TLR-Induced Proinflammatory Cytokine and IFN-β Secretion in Dendritic Cells. The Journal of Immunology. 180(12). 8020–8029. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masahiro Fujii Breakdown of academic impact, for papers by Kristoffer Niss Breakdown of academic impact, for papers by Chengfu Cao Breakdown of academic impact, for papers by Carin Gustavsson Breakdown of academic impact, for papers by Daniëlle Hof Breakdown of academic impact, for papers by Wolfgang Derer Breakdown of academic impact, for papers by Arvind Sood Breakdown of academic impact, for papers by Yudai Shimoda Breakdown of academic impact, for papers by Guerline Lambert Breakdown of academic impact, for papers by Annalisa Moregola
Rankless by CCL
2026